CRO opens new branch office in Berlin
"The last three years have been excellent for FGK. Many of our existing customers have contracted us for further projects. We were also able to convince a whole range of new customers that we are as a service provider an attractive partner for all aspects of clinical research in Europe. At our headquarters in Munich, our opportunities for growth are limited both in terms of space and personnel. Therefore, we have now decided to take advantage of the more relaxed personnel and rental situation in Berlin to attract highly qualified colleagues to our team and to further expand our capacities for our customers," states Martin Krauss, one of the two managing directors of FGK Clinical Research.
FGK Clinical Research is a full-service CRO based in Munich with subsidiaries in Prague, Warsaw and Budapest and now also in Berlin. Since 2002, FGK has been managing clinical studies of phases I to IV throughout Europe, specializing in the cooperation with small to medium-sized biotech, medical device and pharmaceutical companies. The extensive experience of more than 140 employees and an owner-managed company structure enable FGK to manage complex projects flexibly and personally. At the same time, the company is constantly expanding its expertise and keeps pace with the increasing digitalization in the field of clinical studies.